Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Novel transplant strategies in adults with acute leukemia.

Paun O, Lazarus HM.

Hematol Oncol Clin North Am. 2011 Dec;25(6):1319-39, ix. doi: 10.1016/j.hoc.2011.08.001. Review.

PMID:
22093589
3.

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.

4.
5.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

6.

Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.

Novitzky N, Thomas V, du Toit C, McDonald A.

Biol Blood Marrow Transplant. 2011 Jun;17(6):875-84. doi: 10.1016/j.bbmt.2010.09.016. Epub 2010 Sep 24.

7.

Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.

Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, di Grazia C, Dominietto A, Tedone E, Piaggio G, Podesta M, Bruno B, Oneto R, Lombardi A, Frassoni F, Rolla D, Rollandi G, Viscoli C, Ferro C, Garbarino L, Van Lint MT.

Haematologica. 2004 Oct;89(10):1238-47.

8.

[Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].

Michallet M, Dhedin N, Michallet AS.

Bull Cancer. 2001 Sep;88(9):908-26. Review. French.

9.

Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.

Niederwieser D, Gentilini C, Hegenbart U, Lange T, Becker C, Wang SY, Bartsch K, Pönisch W, Raida M, Al-Ali H.

Crit Rev Oncol Hematol. 2005 Nov;56(2):275-81. Epub 2005 Oct 5. Review.

PMID:
16213741
10.

Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.

Lee KH, Choi SJ, Lee JH, Lee JH, Kim DY, Seol M, Lee YS, Kang YA, Jeon M, Yun SC, Joo YD, Lee WS, Kang MJ, Kim H, Park JH, Bae SH, Ryoo HM, Kim MK, Hyun MS.

Am J Hematol. 2011 May;86(5):399-405. doi: 10.1002/ajh.21989.

11.

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM, Braun T, Yanik G, Hutchinson R, Ratanatharathorn V.

Biol Blood Marrow Transplant. 2003 Mar;9(3):189-97.

PMID:
12652470
12.
13.

Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.

Nishihori T, Alsina M.

Cancer Control. 2011 Oct;18(4):258-67. Review.

14.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
15.

Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.

Martino R, Caballero MD, de la Serna J, Díez-Martín JL, Urbano-Ispízua A, Tomás JF, Odriozola J, León A, Canals C, San Miguel J, Sierra J.

Bone Marrow Transplant. 2002 Jul;30(2):63-8.

16.

[Allogeneic hematopoietic stem cell transplantation following reduced intensity conditioning regimen for treatment of refractory leukemia].

Jiang JL, Yan SK, Yang J, Cai Y, Wan LP, Qin YW, Wang C.

Zhonghua Xue Ye Xue Za Zhi. 2008 Aug;29(8):517-21. Chinese.

PMID:
19112913
17.

Immunotherapy by allogeneic stem cell transplantation.

Ringdén O.

Adv Cancer Res. 2007;97:25-60. Review.

PMID:
17419940
18.

CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.

Soiffer RJ, Fairclough D, Robertson M, Alyea E, Anderson K, Freedman A, Bartlett-Pandite L, Fisher D, Schlossman RL, Stone R, Murray C, Freeman A, Marcus K, Mauch P, Nadler L, Ritz J.

Blood. 1997 Apr 15;89(8):3039-47.

20.

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.

Servais S, Baron F, Beguin Y.

Transfus Apher Sci. 2011 Apr;44(2):205-10. doi: 10.1016/j.transci.2011.01.019. Epub 2011 Feb 22. Review.

Supplemental Content

Support Center